| |
 Follow Pharm Exec on Twitter |
 Follow Pharm Exec on Facebook |
 Send Email Feedback |
|
 |
| March 22, 2012 | ISSUE NUMBER 243 VOL 8 |
|
|
| Special Feature Industry Off the Hook? Pharm Exec's 8th Annual Press Survey Our annual press audit finds that the big news in 2011 for pharma was ... no news! The year was the quietest for big daily newspaper coverage of the pharmaceutical industry since we began tracking the data in 2004 ...Read More |
| Legal Prometheus Decision a Harbinger for Myriad? Judging the Prometheus patents invalid, the Supreme Court may have shown its hand on the upcoming Myriad Genetics case ...Read More |
| Comment Journey from Patent Filing to Drug Approval Harder Than Ever Data from law firm Withers & Rogers shows how the numbers of patent filings from the ten leading pharma companies has dropped in recent years. Only 129 “patent families” of drugs in leading markets were sought by the top 10 drug companies in 2009, down from 189 in 2007. Combined with other reports suggesting that regulatory approval has also become harder to obtain, the upshot is that Big Pharma is struggling to refill drug pipelines as their older products come off patent ...Read More |
| World Health Industry Optimism for Advancing TB Research Scientists are optimistic new combination regimens will improve TB treatment and reduce drug resistance, writes Jill Wechsler ...Read More |
| Advertisement Meeting Global Patient Demand for Access to Medicines Prior to Approval and Launch On-Demand Webcast |
 // MichBio (Ann Arbor, MI) announced the appointment of Wendy Wendel (formerly Wendy Ventura) as Director, Marketing & Communications. // Physicians Interactive (Marlborough, MA) named Gautam Gulati as Chief Medical Officer and Senior Vice President of Product Management, and Joe Caso as Executive Vice President of New Business Development. // Catalent Pharma Solutions, Inc. (Somerset, NJ) announced the appointment of Jeremie Trochu to the newly-created position of Vice President, Commercial Excellence. |
| Advertisement Utilization of Rasch Measurement Models for Assessing Validity: A Mixed Methods Approach On-Demand Webcast Click here |
 April 16–17: CBI's 3rd Annual West Cost Forum on Sunshine, State Laws and Aggregate Spend New York, NY April 26–27: 11th Annual Patient Adherence Forum Philadelphia, PA May 7–8: Bio/Pharma Forum on Regulatory Policy Washington, DC |
|
